Encompass Health (EHC)
(Delayed Data from NYSE)
$94.50 USD
-0.23 (-0.24%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $94.48 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Company Summary
Encompass Health Corporation is a provider of integrated healthcare services. It offers facility-based patient care through its network of inpatient rehabilitation hospitals. With a national footprint that includes 162 hospitals across 37 states and Puerto Rico, the company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements.
On Jul 1, 2022, the company completed the spin-off of its home health and hospice business to ...
Company Summary
Encompass Health Corporation is a provider of integrated healthcare services. It offers facility-based patient care through its network of inpatient rehabilitation hospitals. With a national footprint that includes 162 hospitals across 37 states and Puerto Rico, the company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements.
On Jul 1, 2022, the company completed the spin-off of its home health and hospice business to an independent company. Effective on the very same day, the new company named Enhabit, Inc. started “regular-way” trading under the “EHAB” symbol on the New York Stock Exchange (NYSE). Following the separation, Encompass Health has a single reportable segment, which is the Inpatient Rehabilitation.
The company’s Inpatient Rehabilitation hospitals offer specialized rehabilitative care over a wide array of diagnoses and deliver comprehensive, high-quality, cost-effective patient care services. The company provides specialized rehabilitative treatment on both inpatient and outpatient basis.
Encompass Health intends to inaugurate six de novos and add around 150 beds to exisiting hospitals in 2024. It targets to add 80-120 beds on an annual basis in the 2025-2027 period.
General Information
Encompass Health Corporation
9001 LIBERTY PARKWAY
BIRMINGHAM, AL 35242
Phone: 205-967-7116
Fax: 205-969-4719
Web: http://www.encompasshealth.com
Email: mark.miller@encompasshealth.com
Industry | Medical - Outpatient and Home Healthcare |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 9/30/2024 |
Exp Earnings Date | 10/24/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.94 |
Current Year EPS Consensus Estimate | 4.18 |
Estimated Long-Term EPS Growth Rate | 15.80 |
Exp Earnings Date | 10/24/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 94.73 |
52 Week High | 97.56 |
52 Week Low | 57.55 |
Beta | 0.88 |
20 Day Moving Average | 599,167.62 |
Target Price Consensus | 102.73 |
4 Week | 1.43 |
12 Week | 10.28 |
YTD | 41.98 |
4 Week | -2.06 |
12 Week | 8.05 |
YTD | 18.81 |
Shares Outstanding (millions) | 100.62 |
Market Capitalization (millions) | 9,532.24 |
Short Ratio | NA |
Last Split Date | 10/26/2006 |
Dividend Yield | 0.72% |
Annual Dividend | $0.68 |
Payout Ratio | 0.15 |
Change in Payout Ratio | -0.11 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 22.69 |
Trailing 12 Months | 23.45 |
PEG Ratio | 1.44 |
vs. Previous Year | 16.84% |
vs. Previous Quarter | -0.89% |
vs. Previous Year | 9.61% |
vs. Previous Quarter | -1.12% |
Price/Book | 3.84 |
Price/Cash Flow | 14.55 |
Price / Sales | 1.88 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 17.83 |
3/31/24 | 18.01 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 6.68 |
3/31/24 | 6.55 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 1.35 |
3/31/24 | 1.37 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 1.35 |
3/31/24 | 1.37 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 8.13 |
3/31/24 | 7.98 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 7.88 |
3/31/24 | 7.60 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 13.30 |
3/31/24 | 12.90 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 24.66 |
3/31/24 | 23.46 |
9/30/24 | NA |
6/30/24 | NA |
3/31/24 | NA |
9/30/24 | Pending Next EPS Report |
6/30/24 | 1.08 |
3/31/24 | 1.14 |
9/30/24 | Pending Next EPS Report |
6/30/24 | 52.41 |
3/31/24 | 53.55 |